iCliniq Logo
HomeAnswersMedical oncologybreast cancer

Should my daughters be tested for PALB2 since I have IBC?

This Premium Q&A, reviewed and published, features a real conversation between an iCliniq user and a physician.

Patient's Query

Hello doctor,

Dealing with stage 3 inflammatory breast cancer, diagnosed two weeks ago. My skin has a peau d’orange appearance, and my breast size doubled in one month. Three lymph nodes tested positive. A positron emission tomography (PET) scan showed a small spot on my liver, but the radiologist’s report labeled it as indeterminate.

Starting neoadjuvant chemotherapy next week, dose-dense Doxorubicin (Adriamycin) and Cyclophosphamide (AC) followed by Paclitaxel (Taxol), with Carboplatin added. What is the success rate of this combination? Genetic testing showed a partner and localizer of breast cancer gene 2 (PALB2) mutation. Should my daughters (14 and 18) get tested? My skin itches severely. Can I use a corticosteroid cream?

Kindly help.

Hello,

Welcome to icliniq.com.

I can understand your concern.

I am sorry to hear about the diagnosis, and I can imagine it is a lot to process. I will try to provide as much helpful information as possible, but it is always good to talk with your oncologist to get tailored advice.

The combination of dose-dense Doxorubicin (Adriamycin) and Cyclophosphamide, followed by Paclitaxel (Taxol), with Carboplatin, is a well-established chemotherapy regimen for treating inflammatory breast cancer and other aggressive breast cancers.

The addition of Carboplatin is beneficial, particularly for cancers involving lymph nodes and potential metastasis. This regimen aims to shrink the tumor and improve outcomes, but the success rate varies based on individual factors like stage, response to chemotherapy, and tumor biology.

Neoadjuvant chemotherapy is crucial for inflammatory breast cancer, and the response rate to this combination is often good in aggressive but treatable cases.

The PALB2 (Partner and Localizer of BRCA2) gene mutation is associated with an increased risk of breast cancer and other cancers. If you carry a PALB2 mutation, your daughters may also have an elevated risk, so genetic testing can help assess their future cancer risk.

Since breast cancer risk increases significantly with PALB2 mutations, genetic counseling and testing are recommended to guide proactive health decisions. Your daughters should discuss this with a genetic counselor or oncologist to determine the best approach based on their age and individual circumstances.

Itchy skin can occur with inflammatory breast cancer due to changes in the skin caused by the disease. If the itching is persistent and bothersome, discuss topical treatments with your oncologist.

In some cases, mild corticosteroid creams can help reduce inflammation and itching, but your doctor should confirm if it is appropriate for your specific situation. They may recommend a stronger treatment if the itching is due to a more serious inflammatory reaction.

Keep track of your symptoms, and do not hesitate to reach out to your healthcare team for support. They can adjust your treatment as needed to help keep you as comfortable as possible.

I hope this helps, and I wish you strength as you start your treatment.

Thank you.

Medically reviewed byiCliniq medical review team

Published At March 18, 2025
Reviewed AtNovember 17, 2025

Same symptoms don't mean you have the same problem. Consult a doctor now!

Listen to related tracks in our music library

Ask your health query to a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.